Trinity Biotech's total assets for Q3 2024 were $97.45M, an increase of 3.28% from the previous quarter. TRIB total liabilities were $123.79M for the fiscal quarter, a 0.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.